EBS - Emergent BioSolutions to develop hyperimmune candidates for COVID-19 March, 11 2020 04:33 PM Emergent Biosolutions Inc. Emergent BioSolutions (NYSE:EBS) initiates two new programs aimed at treating and preventing coronavirus infection based on its hyperimmune platforms.More news on: Emergent BioSolutions Inc., Healthcare stocks news, Stocks on the move, Read more ...